Myogenesis Promotor, Muscle Atrophy Inhibitor, Medical Composition and Taz Activator
申请人:NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY
公开号:US20160346251A1
公开(公告)日:2016-12-01
The invention provides a novel myogenesis promotor, a novel muscle atrophy inhibitor, a novel composition or a novel TAZ activator. The myogenesis promotor, the muscle atrophy inhibitor, the composition and the TAZ activator include a composition represented by the following Formula (I) as an active ingredient. In Formula (I), R
1
represents a hydrogen atom or an alkyl group; R
2
represents an aryl group, a heterocyclic group, an alkyl group or the like; R
3
represents —NR
5
R
6
or —N═C—R
7
; each of R
5
and R
6
independently represents a hydrogen atom, an alkyl group or the like; R
7
represents —NR
10
R
11
, an aryl group or a heterocyclic group; R
8
represents a hydrogen atom, an alkyl group or the like; R
9
represents a hydrogen atom, an alkyl group or the like; each of R
10
and R
11
independently represents a hydrogen atom, an alkyl group or the like; R
4
represents a cyano group or —C(═O)R
12
; and R
12
represents an aryl group, a heterocyclic group, an alkyl group or the like.